Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review (2020)
Prasher, Parteek 
; Sharma, Mousmee; Aljabali, Alaa A. A; Gupta, Gaurav ; Negi, Poonam; Kapoor, Deepak N; Singh, Inderbir; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Silva, Mateus Webba da; Bakshi, Hamid A; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M ; Dua, Kamal
Fonte: Drug Development Research. Unidade: FCF
Assuntos: FÁRMACOS, COMPOSTOS ORGÂNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review. Drug Development Research, v. 81, p. 837–858, 2020Tradução . . Disponível em: https://doi.org/10.1002/ddr.21704. Acesso em: 13 nov. 2025.APA
Prasher, P., Sharma, M., Aljabali, A. A. A., Gupta, G., Negi, P., Kapoor, D. N., et al. (2020). Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review. Drug Development Research, 81, 837–858. doi:10.1002/ddr.21704NLM
Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, Pinto T de JA, Silva MW da, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review [Internet]. Drug Development Research. 2020 ; 81 837–858.[citado 2025 nov. 13 ] Available from: https://doi.org/10.1002/ddr.21704Vancouver
Prasher P, Sharma M, Aljabali AAA, Gupta G, Negi P, Kapoor DN, Singh I, Zacconi FC, Pinto T de JA, Silva MW da, Bakshi HA, Chellappan DK, Tambuwala MM, Dua K. Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review [Internet]. Drug Development Research. 2020 ; 81 837–858.[citado 2025 nov. 13 ] Available from: https://doi.org/10.1002/ddr.21704
